Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Point of Care Test Market by Application (BLOOD GLUCOSE TESTING, INFECTIOUS DISEASE TESTING, CARDIAC MARKER TESTING, COAGULATION TESTING, BLOOD GAS ELECTROLYTE TESTING, PREGNANCY FERTILITY TESTING, TUMOR MARKER TESTING, CHOLESTEROL TESTING, URINALYSIS) and by End Users (HOSPITALS, DIAGNOSTIC CENTRES, OTHERS): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03437

Pages: NA

Charts: NA

Tables: NA

Point of care test or POCT is the diagnostics test done with the help of electronic and non-electronic devices. It replaces several laboratory and clinical experiments, hence decrease the turnaround time required for the tests. The prime factors that drive the market growth are the rise in demand for POCT among patients, increase in the disposable income and rapid increase in medical tourism in Europe. However, lack of awareness about POC tests restraint the market growth. Moreover, increasing technological developments in the field of POC tests will offer lucrative opportunities for the market growth.

The report segments the market on the basis of applications, end users and countries. Based on application, the market is segmented into blood glucose testing, infectious diseases testing, cardiac markers testing, coagulation testing, blood gas and electrolyte testing, pregnancy and fertility testing, tumour markers testing, cholesterol testing and urinalysis. Based on end users, then market is segmented into hospitals, diagnostics centres and others. Based on country, the market is segmented in France, U.K, Italy, Spain, Germany and rest of Europe.

Key Benefits

  • The study provides an in-depth analysis of the point of care test market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • Comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry is provided for the period to assist stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps in understanding the trends in types of point of care test across Europe.
  • Key market players and their strategies have been provided to understand the competitive outlook of the industry.

 Key Market Segments

  • By Application
    • BLOOD GLUCOSE TESTING
    • INFECTIOUS DISEASE TESTING
    • CARDIAC MARKER TESTING
    • COAGULATION TESTING
    • BLOOD GAS & ELECTROLYTE TESTING
    • PREGNANCY & FERTILITY TESTING
    • TUMOR MARKER TESTING
    • CHOLESTEROL TESTING
    • URINALYSIS
  • By End Users
    • HOSPITALS
    • DIAGNOSTIC CENTRES
    • OTHERS
  • By Region
    • EUROPE
      • . Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe

 
Key Market Players

  • ALERE
  • F. HOFFMANN LA ROCHE LTD
  • BIOMERIEUX S.A
  • DANAHAR CORPORATION
  • BECTON, DICKENSON AND COMPANY (BD)
  • AFFYMETRIX INC. (THERMOFISCHER SCIENTIFIC INC.)
  • ALIGENT TECHNOLOGIES
  • ABBOTT LABORATORIES
  • NOVA BIOMEDICAL
  • LIFESCAN INC.

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: POINT OF CARE TEST MARKET, BY APPLICATION

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Application

    • 4.2. BLOOD GLUCOSE TESTING

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. INFECTIOUS DISEASE TESTING

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. CARDIAC MARKER TESTING

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. COAGULATION TESTING

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. BLOOD GAS And ELECTROLYTE TESTING

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. PREGNANCY And FERTILITY TESTING

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

    • 4.8. TUMOR MARKER TESTING

      • 4.8.1. Key Market Trends, Growth Factors and Opportunities

      • 4.8.2. Market Size and Forecast, By Region

      • 4.8.3. Market Share Analysis, By Country

    • 4.9. CHOLESTEROL TESTING

      • 4.9.1. Key Market Trends, Growth Factors and Opportunities

      • 4.9.2. Market Size and Forecast, By Region

      • 4.9.3. Market Share Analysis, By Country

    • 4.10. URINALYSIS

      • 4.10.1. Key Market Trends, Growth Factors and Opportunities

      • 4.10.2. Market Size and Forecast, By Region

      • 4.10.3. Market Share Analysis, By Country

  • CHAPTER 5: POINT OF CARE TEST MARKET, BY END USERS

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End Users

    • 5.2. HOSPITALS

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. DIAGNOSTIC CENTRES

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. OTHERS

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: POINT OF CARE TEST MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Application

      • 6.2.3. Market Size and Forecast, By End Users

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Point Of Care Test Market

        • 6.2.5.1. Market Size and Forecast, By Application
        • 6.2.5.2. Market Size and Forecast, By End Users

      • 6.2.6. Canada Point Of Care Test Market

        • 6.2.6.1. Market Size and Forecast, By Application
        • 6.2.6.2. Market Size and Forecast, By End Users

      • 6.2.7. Mexico Point Of Care Test Market

        • 6.2.7.1. Market Size and Forecast, By Application
        • 6.2.7.2. Market Size and Forecast, By End Users

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Application

      • 6.3.3. Market Size and Forecast, By End Users

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Point Of Care Test Market

        • 6.3.5.1. Market Size and Forecast, By Application
        • 6.3.5.2. Market Size and Forecast, By End Users

      • 6.3.6. Germany Point Of Care Test Market

        • 6.3.6.1. Market Size and Forecast, By Application
        • 6.3.6.2. Market Size and Forecast, By End Users

      • 6.3.7. Italy Point Of Care Test Market

        • 6.3.7.1. Market Size and Forecast, By Application
        • 6.3.7.2. Market Size and Forecast, By End Users

      • 6.3.8. Spain Point Of Care Test Market

        • 6.3.8.1. Market Size and Forecast, By Application
        • 6.3.8.2. Market Size and Forecast, By End Users

      • 6.3.9. UK Point Of Care Test Market

        • 6.3.9.1. Market Size and Forecast, By Application
        • 6.3.9.2. Market Size and Forecast, By End Users

      • 6.3.10. Russia Point Of Care Test Market

        • 6.3.10.1. Market Size and Forecast, By Application
        • 6.3.10.2. Market Size and Forecast, By End Users

      • 6.3.11. Rest Of Europe Point Of Care Test Market

        • 6.3.11.1. Market Size and Forecast, By Application
        • 6.3.11.2. Market Size and Forecast, By End Users

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Application

      • 6.4.3. Market Size and Forecast, By End Users

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Point Of Care Test Market

        • 6.4.5.1. Market Size and Forecast, By Application
        • 6.4.5.2. Market Size and Forecast, By End Users

      • 6.4.6. Japan Point Of Care Test Market

        • 6.4.6.1. Market Size and Forecast, By Application
        • 6.4.6.2. Market Size and Forecast, By End Users

      • 6.4.7. India Point Of Care Test Market

        • 6.4.7.1. Market Size and Forecast, By Application
        • 6.4.7.2. Market Size and Forecast, By End Users

      • 6.4.8. South Korea Point Of Care Test Market

        • 6.4.8.1. Market Size and Forecast, By Application
        • 6.4.8.2. Market Size and Forecast, By End Users

      • 6.4.9. Australia Point Of Care Test Market

        • 6.4.9.1. Market Size and Forecast, By Application
        • 6.4.9.2. Market Size and Forecast, By End Users

      • 6.4.10. Thailand Point Of Care Test Market

        • 6.4.10.1. Market Size and Forecast, By Application
        • 6.4.10.2. Market Size and Forecast, By End Users

      • 6.4.11. Malaysia Point Of Care Test Market

        • 6.4.11.1. Market Size and Forecast, By Application
        • 6.4.11.2. Market Size and Forecast, By End Users

      • 6.4.12. Indonesia Point Of Care Test Market

        • 6.4.12.1. Market Size and Forecast, By Application
        • 6.4.12.2. Market Size and Forecast, By End Users

      • 6.4.13. Rest of Asia Pacific Point Of Care Test Market

        • 6.4.13.1. Market Size and Forecast, By Application
        • 6.4.13.2. Market Size and Forecast, By End Users

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Application

      • 6.5.3. Market Size and Forecast, By End Users

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Point Of Care Test Market

        • 6.5.5.1. Market Size and Forecast, By Application
        • 6.5.5.2. Market Size and Forecast, By End Users

      • 6.5.6. South Africa Point Of Care Test Market

        • 6.5.6.1. Market Size and Forecast, By Application
        • 6.5.6.2. Market Size and Forecast, By End Users

      • 6.5.7. Saudi Arabia Point Of Care Test Market

        • 6.5.7.1. Market Size and Forecast, By Application
        • 6.5.7.2. Market Size and Forecast, By End Users

      • 6.5.8. UAE Point Of Care Test Market

        • 6.5.8.1. Market Size and Forecast, By Application
        • 6.5.8.2. Market Size and Forecast, By End Users

      • 6.5.9. Argentina Point Of Care Test Market

        • 6.5.9.1. Market Size and Forecast, By Application
        • 6.5.9.2. Market Size and Forecast, By End Users

      • 6.5.10. Rest of LAMEA Point Of Care Test Market

        • 6.5.10.1. Market Size and Forecast, By Application
        • 6.5.10.2. Market Size and Forecast, By End Users

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. ABBOTT LABORATORIES

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. ALIGENT TECHNOLOGIES

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. F. HOFFMANN LA ROCHE LTD

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. AFFYMETRIX INC. (THERMOFISCHER SCIENTIFIC INC.)

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. ALERE

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. LIFESCAN INC.

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. BECTON, DICKENSON AND COMPANY (BD)

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. DANAHAR CORPORATION

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. BIOMERIEUX S.A

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. NOVA BIOMEDICAL

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL POINT OF CARE TEST MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL POINT OF CARE TEST MARKET FOR BLOOD GLUCOSE TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL POINT OF CARE TEST MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL POINT OF CARE TEST MARKET FOR CARDIAC MARKER TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL POINT OF CARE TEST MARKET FOR COAGULATION TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL POINT OF CARE TEST MARKET FOR BLOOD GAS AND ELECTROLYTE TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL POINT OF CARE TEST MARKET FOR PREGNANCY AND FERTILITY TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL POINT OF CARE TEST MARKET FOR TUMOR MARKER TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL POINT OF CARE TEST MARKET FOR CHOLESTEROL TESTING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL POINT OF CARE TEST MARKET FOR URINALYSIS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL POINT OF CARE TEST MARKET, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL POINT OF CARE TEST MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL POINT OF CARE TEST MARKET FOR DIAGNOSTIC CENTRES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL POINT OF CARE TEST MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL POINT OF CARE TEST MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA POINT OF CARE TEST, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 19. U.S. POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 20. U.S. POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 21. CANADA POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 22. CANADA POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 23. MEXICO POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 24. MEXICO POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 25. EUROPE POINT OF CARE TEST, BY REGION, 2025-2033 ($MILLION)
  • TABLE 26. EUROPE POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 27. EUROPE POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 28. FRANCE POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 29. FRANCE POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 30. GERMANY POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 31. GERMANY POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 32. ITALY POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 33. ITALY POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 34. SPAIN POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 35. SPAIN POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 36. UK POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 37. UK POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 38. RUSSIA POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 39. RUSSIA POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 40. REST OF EUROPE POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 41. REST OF EUROPE POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 42. ASIA-PACIFIC POINT OF CARE TEST, BY REGION, 2025-2033 ($MILLION)
  • TABLE 43. ASIA-PACIFIC POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 44. ASIA-PACIFIC POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 45. CHINA POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 46. CHINA POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 47. JAPAN POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 48. JAPAN POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 49. INDIA POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 50. INDIA POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 51. SOUTH KOREA POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 52. SOUTH KOREA POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 53. AUSTRALIA POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 54. AUSTRALIA POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 55. THAILAND POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 56. THAILAND POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 57. MALAYSIA POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 58. MALAYSIA POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 59. INDONESIA POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 60. INDONESIA POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 61. REST OF ASIA PACIFIC POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 62. REST OF ASIA PACIFIC POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 63. LAMEA POINT OF CARE TEST, BY REGION, 2025-2033 ($MILLION)
  • TABLE 64. LAMEA POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 65. LAMEA POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 66. BRAZIL POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 67. BRAZIL POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH AFRICA POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH AFRICA POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 70. SAUDI ARABIA POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 71. SAUDI ARABIA POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 72. UAE POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 73. UAE POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 74. ARGENTINA POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 75. ARGENTINA POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 76. REST OF LAMEA POINT OF CARE TEST, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 77. REST OF LAMEA POINT OF CARE TEST, BY END USERS, 2025-2033 ($MILLION)
  • TABLE 78. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 79. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 80. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 81. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 82. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. ALIGENT TECHNOLOGIES: KEY EXECUTIVES
  • TABLE 84. ALIGENT TECHNOLOGIES: COMPANY SNAPSHOT
  • TABLE 85. ALIGENT TECHNOLOGIES: OPERATING SEGMENTS
  • TABLE 86. ALIGENT TECHNOLOGIES: PRODUCT PORTFOLIO
  • TABLE 87. ALIGENT TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 88. F. HOFFMANN LA ROCHE LTD: KEY EXECUTIVES
  • TABLE 89. F. HOFFMANN LA ROCHE LTD: COMPANY SNAPSHOT
  • TABLE 90. F. HOFFMANN LA ROCHE LTD: OPERATING SEGMENTS
  • TABLE 91. F. HOFFMANN LA ROCHE LTD: PRODUCT PORTFOLIO
  • TABLE 92. F. HOFFMANN LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 93. AFFYMETRIX INC. (THERMOFISCHER SCIENTIFIC INC.): KEY EXECUTIVES
  • TABLE 94. AFFYMETRIX INC. (THERMOFISCHER SCIENTIFIC INC.): COMPANY SNAPSHOT
  • TABLE 95. AFFYMETRIX INC. (THERMOFISCHER SCIENTIFIC INC.): OPERATING SEGMENTS
  • TABLE 96. AFFYMETRIX INC. (THERMOFISCHER SCIENTIFIC INC.): PRODUCT PORTFOLIO
  • TABLE 97. AFFYMETRIX INC. (THERMOFISCHER SCIENTIFIC INC.): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 98. ALERE: KEY EXECUTIVES
  • TABLE 99. ALERE: COMPANY SNAPSHOT
  • TABLE 100. ALERE: OPERATING SEGMENTS
  • TABLE 101. ALERE: PRODUCT PORTFOLIO
  • TABLE 102. ALERE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 103. LIFESCAN INC.: KEY EXECUTIVES
  • TABLE 104. LIFESCAN INC.: COMPANY SNAPSHOT
  • TABLE 105. LIFESCAN INC.: OPERATING SEGMENTS
  • TABLE 106. LIFESCAN INC.: PRODUCT PORTFOLIO
  • TABLE 107. LIFESCAN INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 108. BECTON, DICKENSON AND COMPANY (BD): KEY EXECUTIVES
  • TABLE 109. BECTON, DICKENSON AND COMPANY (BD): COMPANY SNAPSHOT
  • TABLE 110. BECTON, DICKENSON AND COMPANY (BD): OPERATING SEGMENTS
  • TABLE 111. BECTON, DICKENSON AND COMPANY (BD): PRODUCT PORTFOLIO
  • TABLE 112. BECTON, DICKENSON AND COMPANY (BD): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. DANAHAR CORPORATION: KEY EXECUTIVES
  • TABLE 114. DANAHAR CORPORATION: COMPANY SNAPSHOT
  • TABLE 115. DANAHAR CORPORATION: OPERATING SEGMENTS
  • TABLE 116. DANAHAR CORPORATION: PRODUCT PORTFOLIO
  • TABLE 117. DANAHAR CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. BIOMERIEUX S.A: KEY EXECUTIVES
  • TABLE 119. BIOMERIEUX S.A: COMPANY SNAPSHOT
  • TABLE 120. BIOMERIEUX S.A: OPERATING SEGMENTS
  • TABLE 121. BIOMERIEUX S.A: PRODUCT PORTFOLIO
  • TABLE 122. BIOMERIEUX S.A: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123. NOVA BIOMEDICAL: KEY EXECUTIVES
  • TABLE 124. NOVA BIOMEDICAL: COMPANY SNAPSHOT
  • TABLE 125. NOVA BIOMEDICAL: OPERATING SEGMENTS
  • TABLE 126. NOVA BIOMEDICAL: PRODUCT PORTFOLIO
  • TABLE 127. NOVA BIOMEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL POINT OF CARE TEST MARKET SEGMENTATION
  • FIGURE 2. GLOBAL POINT OF CARE TEST MARKET
  • FIGURE 3. SEGMENTATION POINT OF CARE TEST MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN POINT OF CARE TEST MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALPOINT OF CARE TEST MARKET
  • FIGURE 11. POINT OF CARE TEST MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 12. POINT OF CARE TEST MARKET FOR BLOOD GLUCOSE TESTING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. POINT OF CARE TEST MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. POINT OF CARE TEST MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. POINT OF CARE TEST MARKET FOR COAGULATION TESTING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. POINT OF CARE TEST MARKET FOR BLOOD GAS AND ELECTROLYTE TESTING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. POINT OF CARE TEST MARKET FOR PREGNANCY AND FERTILITY TESTING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. POINT OF CARE TEST MARKET FOR TUMOR MARKER TESTING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. POINT OF CARE TEST MARKET FOR CHOLESTEROL TESTING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. POINT OF CARE TEST MARKET FOR URINALYSIS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. POINT OF CARE TEST MARKET SEGMENTATION, BY BY END USERS
  • FIGURE 22. POINT OF CARE TEST MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. POINT OF CARE TEST MARKET FOR DIAGNOSTIC CENTRES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. POINT OF CARE TEST MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 26. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 28. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 29. COMPETITIVE DASHBOARD
  • FIGURE 30. COMPETITIVE HEATMAP: POINT OF CARE TEST MARKET
  • FIGURE 31. TOP PLAYER POSITIONING, 2024
  • FIGURE 32. ABBOTT LABORATORIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. ALIGENT TECHNOLOGIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. ALIGENT TECHNOLOGIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. ALIGENT TECHNOLOGIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. F. HOFFMANN LA ROCHE LTD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. F. HOFFMANN LA ROCHE LTD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. F. HOFFMANN LA ROCHE LTD: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. AFFYMETRIX INC. (THERMOFISCHER SCIENTIFIC INC.): NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. AFFYMETRIX INC. (THERMOFISCHER SCIENTIFIC INC.): REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. AFFYMETRIX INC. (THERMOFISCHER SCIENTIFIC INC.): REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. ALERE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. ALERE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. ALERE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. LIFESCAN INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. LIFESCAN INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. LIFESCAN INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. BECTON, DICKENSON AND COMPANY (BD): NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. BECTON, DICKENSON AND COMPANY (BD): REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. BECTON, DICKENSON AND COMPANY (BD): REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. DANAHAR CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. DANAHAR CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. DANAHAR CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. BIOMERIEUX S.A: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. BIOMERIEUX S.A: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. BIOMERIEUX S.A: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. NOVA BIOMEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. NOVA BIOMEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. NOVA BIOMEDICAL: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Point of Care Test Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved